Cargando…

Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival

BACKGROUND: Hyperoxemia may aggravate reperfusion brain injury after cardiac arrest. The aim of this study was to study the associations between different levels of hyperoxemia in the reperfusion period after cardiac arrest and 30-day survival. METHODS: Nationwide observational study using data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, Akil, Nordberg, Per, Jonsson, Martin, Hofmann, Robin, Ringh, Mattias, Hollenberg, Jacob, Olson, Jens, Joelsson-Alm, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990272/
https://www.ncbi.nlm.nih.gov/pubmed/36879330
http://dx.doi.org/10.1186/s13054-023-04379-9
_version_ 1784901905159290880
author Awad, Akil
Nordberg, Per
Jonsson, Martin
Hofmann, Robin
Ringh, Mattias
Hollenberg, Jacob
Olson, Jens
Joelsson-Alm, Eva
author_facet Awad, Akil
Nordberg, Per
Jonsson, Martin
Hofmann, Robin
Ringh, Mattias
Hollenberg, Jacob
Olson, Jens
Joelsson-Alm, Eva
author_sort Awad, Akil
collection PubMed
description BACKGROUND: Hyperoxemia may aggravate reperfusion brain injury after cardiac arrest. The aim of this study was to study the associations between different levels of hyperoxemia in the reperfusion period after cardiac arrest and 30-day survival. METHODS: Nationwide observational study using data from four compulsory Swedish registries. Adult in- and out-of-hospital cardiac arrest patients admitted to an ICU, requiring mechanical ventilation, between January 2010 and March 2021, were included. The partial oxygen pressure (PaO(2)) was collected in a standardized way at ICU admission (± one hour) according to the simplified acute physiology score 3 reflecting the time interval with oxygen treatment from return of spontaneous circulation to ICU admission. Subsequently, patients were divided into groups based on the registered PaO(2) at ICU admission. Hyperoxemia was categorized into mild (13.4–20 kPa), moderate (20.1–30 kPa) severe (30.1–40 kPa) and extreme (> 40 kPa), and normoxemia as PaO(2) 8–13.3 kPa. Hypoxemia was defined as PaO(2) < 8 kPa. Primary outcome was 30-day survival and relative risks (RR) were estimated by multivariable modified Poisson regression. RESULTS: In total, 9735 patients were included of which 4344 (44.6%) were hyperoxemic at ICU admission. Among these, 2217 were classified as mild, 1091 as moderate, 507 as severe, and 529 as extreme hyperoxemia. Normoxemia was present in 4366 (44.8%) patients and 1025 (10.5%) had hypoxemia. Compared to the normoxemia group, the adjusted RR for 30-day survival in the whole hyperoxemia group was 0.87 (95% CI 0.82–0.91). The corresponding results for the different hyperoxemia subgroups were; mild 0.91 (95% CI 0.85–0.97), moderate 0.88 (95% CI 0.82–0.95), severe 0.79 (95% CI 0.7–0.89), and extreme 0.68 (95% CI 0.58–0.79). Adjusted 30-day survival for the hypoxemia compared to normoxemia group was 0.83 (95% CI 0.74–0.92). Similar associations were seen in both out-of-hospital and in-hospital cardiac arrests. CONCLUSION: In this nationwide observational study comprising both in- and out-of-hospital cardiac arrest patients, hyperoxemia at ICU admission was associated with lower 30-day survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-023-04379-9.
format Online
Article
Text
id pubmed-9990272
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99902722023-03-08 Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival Awad, Akil Nordberg, Per Jonsson, Martin Hofmann, Robin Ringh, Mattias Hollenberg, Jacob Olson, Jens Joelsson-Alm, Eva Crit Care Research BACKGROUND: Hyperoxemia may aggravate reperfusion brain injury after cardiac arrest. The aim of this study was to study the associations between different levels of hyperoxemia in the reperfusion period after cardiac arrest and 30-day survival. METHODS: Nationwide observational study using data from four compulsory Swedish registries. Adult in- and out-of-hospital cardiac arrest patients admitted to an ICU, requiring mechanical ventilation, between January 2010 and March 2021, were included. The partial oxygen pressure (PaO(2)) was collected in a standardized way at ICU admission (± one hour) according to the simplified acute physiology score 3 reflecting the time interval with oxygen treatment from return of spontaneous circulation to ICU admission. Subsequently, patients were divided into groups based on the registered PaO(2) at ICU admission. Hyperoxemia was categorized into mild (13.4–20 kPa), moderate (20.1–30 kPa) severe (30.1–40 kPa) and extreme (> 40 kPa), and normoxemia as PaO(2) 8–13.3 kPa. Hypoxemia was defined as PaO(2) < 8 kPa. Primary outcome was 30-day survival and relative risks (RR) were estimated by multivariable modified Poisson regression. RESULTS: In total, 9735 patients were included of which 4344 (44.6%) were hyperoxemic at ICU admission. Among these, 2217 were classified as mild, 1091 as moderate, 507 as severe, and 529 as extreme hyperoxemia. Normoxemia was present in 4366 (44.8%) patients and 1025 (10.5%) had hypoxemia. Compared to the normoxemia group, the adjusted RR for 30-day survival in the whole hyperoxemia group was 0.87 (95% CI 0.82–0.91). The corresponding results for the different hyperoxemia subgroups were; mild 0.91 (95% CI 0.85–0.97), moderate 0.88 (95% CI 0.82–0.95), severe 0.79 (95% CI 0.7–0.89), and extreme 0.68 (95% CI 0.58–0.79). Adjusted 30-day survival for the hypoxemia compared to normoxemia group was 0.83 (95% CI 0.74–0.92). Similar associations were seen in both out-of-hospital and in-hospital cardiac arrests. CONCLUSION: In this nationwide observational study comprising both in- and out-of-hospital cardiac arrest patients, hyperoxemia at ICU admission was associated with lower 30-day survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-023-04379-9. BioMed Central 2023-03-06 /pmc/articles/PMC9990272/ /pubmed/36879330 http://dx.doi.org/10.1186/s13054-023-04379-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Awad, Akil
Nordberg, Per
Jonsson, Martin
Hofmann, Robin
Ringh, Mattias
Hollenberg, Jacob
Olson, Jens
Joelsson-Alm, Eva
Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival
title Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival
title_full Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival
title_fullStr Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival
title_full_unstemmed Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival
title_short Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival
title_sort hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990272/
https://www.ncbi.nlm.nih.gov/pubmed/36879330
http://dx.doi.org/10.1186/s13054-023-04379-9
work_keys_str_mv AT awadakil hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival
AT nordbergper hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival
AT jonssonmartin hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival
AT hofmannrobin hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival
AT ringhmattias hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival
AT hollenbergjacob hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival
AT olsonjens hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival
AT joelssonalmeva hyperoxemiaafterreperfusionincardiacarrestpatientsapotentialdoseresponseassociationwith30daysurvival